The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A phase 1-2, first-in-human, open label, dose escalation and expansion study of AU-007, a monoclonal antibody that binds to IL-2 and inhibits IL-2Rα binding, in patients with advanced solid tumors.
 
James Robert Vasselli
Employment - Aulos Bioscience
Stock and Other Ownership Interests - Aulos Bioscience; Maverick Therapeutics
 
Sophia Frentzas
Consulting or Advisory Role - GOG Foundation; MSD Oncology
 
Andrew James Weickhardt
Honoraria - Eisai; Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
Speakers' Bureau - Astellas Pharma
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Merck Sharp & Dohme
 
Paul L. de Souza
Stock and Other Ownership Interests - Filamon Pty
Consulting or Advisory Role - Biosceptre International; Harbour BioMed
 
Jenny Tang
Employment - Aulos Bioscience
Stock and Other Ownership Interests - Aulos Bioscience
 
Tim Wyant
Employment - Aulos Bioscience; Biolojic
Stock and Other Ownership Interests - Aulos Bioscience
 
Inbar Amit
Employment - Aulos Bioscience; Biolojic
 
Yanay Ofran
Employment - Aulos Bioscience; Biolojic
Stock and Other Ownership Interests - Aulos Bioscience; Biolojic
Patents, Royalties, Other Intellectual Property - Biolojic
 
Aron Knickerbocker
Employment - Aulos Bioscience
Leadership - KAHR Medical; Phenomic AI; RayzeBio
Stock and Other Ownership Interests - Aulos Bioscience